Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found 2125 records

$100,000.00

Oct 1, 2014
Description:

The Effects of Psoriatic Arthritis on Coronary Flow Reserve and Markers of Inflammation and Evaluation of the Response to Biological Therapy

Organization: Canadian Institutes of Health Research
Location: Ottawa, Ontario, CA K1Y 4W7

$1,349,755.00

Oct 1, 2014
Description:

Fetal Atrial Flutter & Supraventricular Tachycardia (FAST) Therapy Trial: Proposal of an International Registry and Randomized Controlled Trial (RCT)

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5G 1X8

$100,000.00

Oct 1, 2014
Description:

A pragmatic randomized controlled trial of group transdiagnostic cognitive-behaviour therapy for anxiety disorders in primary care

Organization: Canadian Institutes of Health Research
Location: Sherbrooke, Quebec, CA J1K 2R1

$100,000.00

Oct 1, 2014
Description:

The Coming Revolution in HCV Therapy: Will HIV-HCV co-infected patients really benefit?

Organization: Canadian Institutes of Health Research
Location: Montreal, Quebec, CA H3G 1A4

$250,468.00

Oct 1, 2014
Description:

Cochlear gene therapy targeting the protection against aging related hearing loss and neuronal degeneration

Organization: Canadian Institutes of Health Research
Location: Halifax, Nova Scotia, CA B3H 3J5

$495,930.00

Oct 1, 2014
Description:

Exploiting synthetic lethality in Renal Cell Carcinoma: Targeting the loss of the von Hippel-Lindau tumor suppressor gene through autophagy for the development of anticancer therapy

Organization: Canadian Institutes of Health Research
Location: Moncton, New Brunswick, CA E1A 3E9

$100,000.00

Oct 1, 2014
Description:

Gene Therapy for PAX6-Aniridia: Focusing on the Eye

Organization: Canadian Institutes of Health Research
Location: Vancouver, British Columbia, CA V6T 1Z1

$100,000.00

Oct 1, 2014
Description:

The role of NMNAT2, a new p53 target gene, in feedback regulation of p53 function via the SIRT deacetylases.

Organization: Canadian Institutes of Health Research
Location: Halifax, Nova Scotia, CA B3H 3J5

$654,884.00

Oct 1, 2014
Description:

Host-Mediated Control of Virulence and Immunity Genes in Vibrio cholerae

Organization: Canadian Institutes of Health Research
Location: Edmonton, Alberta, CA T6G 2E1

$366,920.00

Oct 1, 2014
Description:

Exenatide and Insulin Glargine Combination Therapy for the Preservation of Pancreatic Beta-cell Function in Early Type 2 Diabetes: A Randomized Controlled Trial

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5G 1X5